Risk factors and incidence of central venous access device-related thrombosis in hospitalized children: a systematic review and meta-analysis

M Fu, Q Yuan, Q Yang, Y Yu, W Song, X Qin, Y Luo… - Pediatric …, 2024 - nature.com
Background The risk factors for central venous access device-related thrombosis (CRT) in
children are not fully understood. We used evidence-based medicine to find the risk factors …

A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including …

Z Hu, Y Persaud, S Ahuja - Critical Reviews in Oncology/Hematology, 2024 - Elsevier
Asparaginase is essential in the initial management of acute lymphoblastic leukemia (ALL)
but frequently leads to venous thromboembolism (VTE). Using anticoagulants for primary …

Efficacy and safety of antithrombotic therapy for preventing and treating pediatric thromboembolic disease: a systematic review

H Gao, M Chen, Y Huang, H Liu, Y Lin, M Chen - Scientific Reports, 2024 - nature.com
This review used traditional and network meta-analyses (NMA) to conduct a comprehensive
study of antithrombotic therapies in children with thromboembolic disease. We searched the …

Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease

M Albisetti, I Tartakovsky, J Halton… - Journal of the …, 2024 - Am Heart Assoc
Background Congenital heart disease (CHD) is common in children and associated with
greater risk of thrombotic complications. Management of these complications with standard …

[HTML][HTML] Anticoagulation of pediatric patients with venous thromboembolism in 2023

CH van Ommen, SE Luijnenburg - Thrombosis Research, 2024 - Elsevier
Venous thromboembolism (VTE) is a rare and heterozygous disease in children.
Management of VTE in children is complicated by age-related differences in epidemiology …

Device Related Thrombosis and Bleeding in Pediatric Health Care: A Meta-analysis

A Ullman, A Hyun, V Gibson, F Newall… - Hospital …, 2024 - publications.aap.org
CONTEXT The risk of invasive device–related thrombosis and bleeding contributes to
morbidity and mortality, yet their prevalence by device-types is poorly understood …

NET-targeted nanoparticles for antithrombotic therapy in pregnancy

Y Zhou, L Xu, P Jin, N Li, X Chen, A Yang, H Qi - Iscience, 2024 - cell.com
Pulmonary embolism caused by deep vein thrombosis (DVT) is a major contributor to
maternal morbidity and mortality. There is still an unmet need for safe and effective treatment …

Mycoplasma pneumoniae pneumonia-associated thromboembolism with plastic bronchitis: a series of five case reports and literature review

P Jin, C Han, W Guo, Y Xu - Italian Journal of Pediatrics, 2024 - Springer
Background Mycoplasma pneumoniae pneumonia is a common respiratory infection among
children. However, the occurrence of thromboembolism with plastic bronchitis in association …

Interventional Treatment of Pediatric Venous Thromboembolic Disease

E Herzog, V Zavaletta, D Katz, J Lindquist… - Techniques in Vascular …, 2024 - Elsevier
This review explores the clinical presentation of lower extremity DVT and pulmonary
embolism (PE), treatment strategies, and outcomes for venous thromboembolism (VTE) in …

Vascular complications in craniopharyngioma-resected paediatric patients: a single-center experience

B Castelli, M Scagnet, F Mussa, L Genitori… - Frontiers in …, 2024 - frontiersin.org
Background Craniopharyngioma (CP), although slow growing and histologically benign, has
high morbidity, mostly related to hypothalamus-pituitary dysfunction and electrolyte …